The novel approach of this peptide represents a exciting advance in the handling of the condition. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – providing enhanced sugar control and anticipated reduction in weight. Scientists are investigating its long-term benefits and role in the overall diabetes c